Case study
Case study
Case study
Case study
Phase 3 Study in Ultra Rare Disease
Phase 3 Study in Ultra Rare Disease
Phase 3 Study in Ultra Rare Disease
Phase 3 Study in Ultra Rare Disease
Adnexi's proprietary platform acclerates clinical trial enrollment through screening
Adnexi's proprietary platform acclerates clinical trial enrollment through screening
Adnexi's proprietary platform acclerates clinical trial enrollment through screening
Adnexi's proprietary platform acclerates clinical trial enrollment through screening
Situation
A biopharmaceutical company developing innovative therapies for people with rare debilitating diseases sought to accelerate trial enrollment
Situation
A biopharmaceutical company developing innovative therapies for people with rare debilitating diseases sought to accelerate trial enrollment
Situation
A biopharmaceutical company developing innovative therapies for people with rare debilitating diseases sought to accelerate trial enrollment
Situation
A biopharmaceutical company developing innovative therapies for people with rare debilitating diseases sought to accelerate trial enrollment
The Approach
Accelerate clinical trial enrollment
Achieve full enrollment
We designed and implemented a compliant patient lead generation program
Patients were directed to a clinical trial website with prescreener
Authorized clinical trial personnel were able to securely access data for patient screening and enrollment via our proprietary Portal
The Approach
Accelerate clinical trial enrollment
Achieve full enrollment
We designed and implemented a compliant patient lead generation program
Patients were directed to a clinical trial website with prescreener
Authorized clinical trial personnel were able to securely access data for patient screening and enrollment via our proprietary Portal
The Approach
Accelerate clinical trial enrollment
Achieve full enrollment
We designed and implemented a compliant patient lead generation program
Patients were directed to a clinical trial website with prescreener
Authorized clinical trial personnel were able to securely access data for patient screening and enrollment via our proprietary Portal
The Approach
Accelerate clinical trial enrollment
Achieve full enrollment
We designed and implemented a compliant patient lead generation program
Patients were directed to a clinical trial website with prescreener
Authorized clinical trial personnel were able to securely access data for patient screening and enrollment via our proprietary Portal
Results
82 patients completed pre-screen
46 patients completed screening at an active site
22 patients randomized in 12 months (~30% of trial)
Results
82 patients completed pre-screen
46 patients completed screening at an active site
22 patients randomized in 12 months (~30% of trial)
Results
82 patients completed pre-screen
46 patients completed screening at an active site
22 patients randomized in 12 months (~30% of trial)
Results
82 patients completed pre-screen
46 patients completed screening at an active site
22 patients randomized in 12 months (~30% of trial)
Ready to transform your medical research and development?
Ready to transform your medical research and development?
Fill out the contact form, and our team will reach out to schedule your personalized demo.
Fill out the contact form, and our team will reach out to schedule your personalized demo.
Fill out the contact form, and our team will reach out to schedule your personalized demo.
Fill out the contact form, and our team will reach out to schedule your personalized demo.
© 2024 Adnexi All rights reserved.
Privacy Policy
Terms & Conditions
Project: Tolv Studio